COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Blood Advances Année : 2022

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

1 University Hospital of Cologne [Cologne]
2 University of Cologne
3 Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
4 UNIMI - Università degli Studi di Milano = University of Milan
5 IRE - IFO - Istituto Nazionale Tumori Regina Elena [Roma]
6 VHIO - Vall d'Hebron Institute of Oncology [Barcelone]
7 UAB - Universitat Autònoma de Barcelona = Autonomous University of Barcelona = Universidad Autónoma de Barcelona
8 AP-HP - Hopital Saint-Louis [AP-HP]
9 CHU Saint-Antoine [AP-HP]
10 CRSA - Centre de Recherche Saint-Antoine
11 IGMM - Institut de Génétique Moléculaire de Montpellier
12 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
13 IRCCS Ospedale San Raffaele [Milan, Italy]
14 University Hospital Brno
15 University Hospital Centre Zagreb
16 University of Zagreb
17 Karolinska University Hospital [Stockholm]
18 FJD - Fundacion Jimenez Diaz [Madrid]
19 Comenius University in Bratislava
20 Hospital Universitario Virgen del Rocío [Sevilla]
21 Hospital Universitario La Paz
22 Hospital Universitario de Salamanca
23 Clinic Barcelona Hospital Universitari
24 University Hospital Basel [Basel]
25 Unibas - Université de Bâle = University of Basel = Basel Universität
26 KCH - King's College Hospital
27 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
28 UC San Diego - University of California [San Diego]
29 Medical University of Graz
30 North-Western State Medical University [St Petersburg, Russia]
31 Uninsubria - Universitá degli Studi dell’Insubria = University of Insubria [Varese]
32 DZIF - German Centre for Infection Research
33 Fondazione Policlinico Universitario Agostino Gemelli IRCCS
34 Unicatt - Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma]
Alessandro Busca
Roberta Di Blasi
Barbora Weinbergerová
Alberto López-García
Ľuboš Drgoňa
Iker Falces-Romero
Austin Kulasekararaj
Antonio Pagliuca

Résumé

Key Points The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
Fichier principal
Vignette du fichier
advancesadv2021005616.pdf (868.29 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03645421 , version 1 (19-04-2022)

Licence

Identifiants

Citer

Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, et al.. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Advances, 2022, 6 (7), pp.2427-2433. ⟨10.1182/bloodadvances.2021005616⟩. ⟨hal-03645421⟩
44 Consultations
41 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More